Verified investment lower bound≥$37.39M
Investment cases6
Manager operating history—
Representative investments
Individual transactions and cumulative snapshots use different bases. Do not add these rows again to cumulative totals.
| Date | Company | Round | Original-currency amount | Paying entity | Specific funds | Sources |
|---|---|---|---|---|---|---|
| 2025-12-30 | Insilico Medicine（英矽智能） | IPO最终获配认购 | HKD 58.14M | Huang River Investment Limited / Tencent | — | Sources · 2
Basis and notes基石1,617,500股＋额外国际配售800,000股，合计2,417,500股×HK$24.05。按最终配售计算认购款，不含费用，不声称银行流水已核。上市日为交易事件日期，非银行付款日。美元仅使用本站既有汇率快照；不是按当前股价计算。 |
| 2024-08 | 智谱（Z.ai） | B4 | CNY 200M | 广西腾讯创业投资有限公司 | — | Sources · 1
Basis and notes招股书印刷页119认购代价；轮次已完成，全部Pre-IPO代价已结清（印刷页128）。不含老股转让、天使轮知识产权作价；票据仅按转股本金计一次。 |